Please login to the form below

Not currently logged in
Email:
Password:

Liptruzet

This page shows the latest Liptruzet news and features for those working in and with pharma, biotech and healthcare.

Merck profit slides as generics continue to bite

Merck profit slides as generics continue to bite

Merck is hoping to re-inject growth into the cholesterol franchise with the ongoing roll-out of Liptruzet (ezetimibe and atorvastatin) in the US. .

Latest news

  • Merck & Co wins green light in US for Zetia-Lipitor combo Merck & Co wins green light in US for Zetia-Lipitor combo

    Vytorin extension wins FDA approval. Merck &Co has been awarded marketing approval for Liptruzet, a new combination cholesterol treatment based on Zetia and generic atorvastatin. ... Merck is upfront about the capabilities of the new therapy, indicating

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics